IBI376 in Patients With Relapsed or Refractory Follicular Lymphoma/Marginal Zone Lymphoma
Clinical trial NCT04298879 · COMPLETED
Trial details
- NCT number
- NCT04298879
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-07
- Primary completion
- 2021-07-27
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.